Evidence map›Paper›PMID 27222290›Full record

ArticleEuropean journal of human genetics : EJHG2016

A non-coding variant in the 5' UTR of DLG3 attenuates protein translation to cause non-syndromic intellectual disability.

Raman Kumar, Thuong Ha, Duyen Pham, Marie Shaw, Marie Mangelsdorf, Kathryn L Friend, Lynne Hobson, Gillian Turner, Jackie Boyle, Michael Field and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. 5'-UTR SNP ofeLife · 2021
    Article
  3. A NovelMolecular syndromology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Raman KumarSchool of Medicine and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
Thuong HaSchool of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
Duyen PhamSchool of Medicine and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
Marie ShawSchool of Medicine and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
Marie MangelsdorfQueensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
Kathryn L FriendGenetics and Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.
Lynne HobsonGenetics and Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.
Gillian TurnerThe GOLD service Hunter Genetics, University of Newcastle, Newcastle, New South Wales, Australia.
Jackie BoyleThe GOLD service Hunter Genetics, University of Newcastle, Newcastle, New South Wales, Australia.
Michael FieldThe GOLD service Hunter Genetics, University of Newcastle, Newcastle, New South Wales, Australia.
Anna HackettThe GOLD service Hunter Genetics, University of Newcastle, Newcastle, New South Wales, Australia.
Mark CorbettSchool of Medicine and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
Jozef GeczSchool of Medicine and the Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
University of Adelaide · AUHunter Genetics · AUSouth Australia Pathology · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intellectual disability (ID) is a clinically complex and heterogeneous disorder, which has variable severity and may be associated with additional dysmorphic, metabolic, neuromuscular or psychiatric features. Although many coding variants have been implicated in ID, identification of pathogenic non-coding regulatory variants has only been achieved in a few cases to date. We identified a duplication of a guanine on chromosome X, NC_000023.10:g.69665044dupG 7 nucleotides upstream of the translational start site in the 5' untranslated region (UTR) of the known ID gene DLG3 that encodes synapse-associated protein 102 (SAP102). The dupG variant segregated with affected status in a large multigenerational family with non-syndromic X-linked ID and was predicted to disrupt folding of the mRNA. When tested on blood cells from the affected individuals, DLG3 mRNA levels were not altered, however, DLG3/SAP102 protein levels were. We also showed by dual luciferase reporter assay that the dupG variant interfered with translation. All currently known pathogenic DLG3 variants are predicted to be null, however the dupG variant likely leads to only a modest reduction of SAP102 levels accounting for the milder phenotype seen in this family.

Indexed as

Mutagenesis, Insertional5' Untranslated RegionsAdultAgedAged, 80 and overCell Line, TumorChromosomes, Human, XFemaleHEK293 CellsHumansMaleMiddle AgedNuclear ProteinsPedigreeRNA FoldingRNA, Messenger5' Untranslated RegionsDLG3 protein, humanNuclear ProteinsRNA, MessengerTranscription Factors

Identifiers

PMID27222290
PMCPMC5110046
OpenAlexW2407966198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.